Table 4 The therapeutic methods of two groups of patients with cryptococcosis [n(%)]
Treatment programs | Immunocompromised group (n = 24) | Immunocompetent group (n = 26) | Total | ||
|---|---|---|---|---|---|
Incorporate hidden brain (n = 6) | Uncombined hidden brain (n = 18) | Incorporate hidden brain (n = 1) | Uncombined hidden brain (n = 25) | ||
Fluconazole | 0 | 17 | 0 | 24 | 41 |
Fluconazole + amphotericin B* | 2 | 0 | 0 | 0 | 2 |
Flucytosine + amphotericin B | 2 | 0 | 1 | 0 | 3 |
Three-drug combinationa | 2 | 0 | 0 | 0 | 2 |
Itraconazole | 1 | 0 | 0 | 0 | 0 |
Surgery | 1 | 4 | 0 | 2 | 7 |
Unused drugs | 0 | 1 | 0 | 1 | 2 |